MTVA (MetaVia) Earnings per share for the last twelve months
High R&D costs and strict FDA oversight limit entry into neuropharmaceuticals, while long-term catalysts for molecule testing currently create a speculative backdrop. The year-over-year change in net income per share over a rolling period confirms these trends, with the value holding at 79.90. MetaVia Inc maintains flexibility by fully outsourcing production and clinical trials to external partners.
%20Net%20earnings%20per%20share%20(EPS%20TTM)&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_MTVA_-_MetaVia-Inc_-_Net-earnings-per-share-EPS-TTM "MTVA (MetaVia, Inc.) Net earnings per share for the last four quarters history from 11/23/2025 to 11/14/2026 | 👁️GURU.Markets👁️")
MetaVia, Inc. - analytical breakdowns and key metrics (MTVA)
- current quotes and average value forecast:
- business market valuation indicators:
- balance sheet net asset value indicators:
- company total debt and liquidity indicators:
All Debt to Shareholders' Equity Ratio MetaVia Inc|MTVA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient MetaVia Inc|MTVA - Company Debts|Debt to Book Value Ratio MetaVia, Inc.|MTVA - Company Long-Term Debts|Company Current Liabilities MetaVia|Quick Liquidity Indicator metaviatx.com
- business earnings and investment ratios data:
MTVA - Net Income|Future Net Profit MetaVia Inc|MTVA - Price to Earnings Ratio|Future Price to Earnings MetaVia Inc|MTVA - PEG Multiple|EV/EBITDA Multiple MetaVia, Inc.|MTVA - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months MetaVia|MTVA - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months metaviatx.com|MTVA - Net earnings per share growth this year|Earnings growth forecast for next year MetaVia Inc
- sales and revenue indicators:
Initial company analysis:MetaVia, MTVA
This indicator measures the rate of change in earnings per share over a rolling twelve-month period, neutralizing seasonal distortions and demonstrating the actual efficiency of capital generation. By analyzing the year-over-year EPS trend (over 12 months), an investor can assess how the scientific progress of MetaVia Inc (MTVA) in the therapy of neurodegenerative diseases converts into financial growth, confirming the fundamental resilience of the business.
Competitor analysis for MetaVia Inc
BIIB - Net earnings per share (EPS TTM)|NBIX (Neurocrine Biosciences, Inc.) - Net earnings per share for the last 12 months|RGC (Regencell Bioscience Ltd) - Earnings per share for the last twelve months|AXSM (Axsome Therapeutics Inc) - Net earnings per share (EPS TTM)|ACADIA Corp (ACAD) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) XENE|Net earnings per share (EPS TTM) vikingtherapeutics.com (VKTX)|Supernus - Net earnings per share for the last 12 months|Earnings per share for the trailing year CPRX|Denali Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Harmony Corp HRMY|Biohaven Ltd. (BHVN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months AMLX|TRVI (Trevi Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Praxis Precision Medicines Inc (PRAX)|Earnings per share for the last twelve months Anavex Corp (AVXL)|Net earnings per share for the last 12 months CeriBell EEG CBLL|Prothena Corporation - Net earnings per share for the last 12 months|Earnings per share for the last four quarters ALEC (Alector Inc.)|ANNX: Net earnings per share for the last 12 months|OMER: Earnings per share for the last twelve months|NGNE: Net earnings per share (EPS TTM)|AC Immune Inc (ACIU) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Voyager Therapeutics|Earnings per share for the last 12 months NMRA (neumoratx.com)|Net earnings per share (EPS TTM) SCLX|TVGN - Net earnings per one share for the last twelve months|Alpha Cognition Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) cogrx.com CGTX|IKT - Earnings per share for the last twelve months|Earnings per share for the trailing year SAVA (cassavasciences.com)|assertiotx.com (ASRT) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Coya Therapeutics (COYA)|Earnings per share for the last twelve months VistaGen Therapeutics, Inc.|Net earnings per share for the last 12 months Ovid Rx (OVID)|Net earnings per share (EPS TTM) ABOS|CRVO - Net earnings per one share for the last twelve months|Alterity Therapeutics Limited - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CLNN (Clene Inc)|PepGen Corp - Net earnings per share (EPS TTM)|JUNS - Net earnings per share (EPS TTM)|RLMD (Relmada Therapeutics) - Net earnings per share for the last 12 months|ANVS (annovisbio.com) - Earnings per share for the last twelve months|GRCE (Grace Therapeutics Inc) - Net earnings per share (EPS TTM)|Firefly Neuroscience, Inc. (AIFF) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) KLTO|Net earnings per share (EPS TTM) neurosense-tx.com (NRSN)|Reviva Pharmaceuticals - Net earnings per share for the last 12 months|Earnings per share for the trailing year NRXS|Helius Medical Technologies Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Passage Bio, Inc. PASG|bionomics.com.au (NEUP) - Earnings per share for the last twelve months|Earnings per share for the last 12 months NERV|ATHA (Athira Pharma, Inc.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months addextherapeutics.com (ADXN)|Earnings per share for the last twelve months Alzamend Neuro, Inc. (ALZN)|Net earnings per share for the last 12 months cyclerion.com CYCN|Protagenic Therapeutics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters KTTA (Pasithea Therapeutics Corp)|CRGT: Net earnings per share for the last 12 months|ATXI: Earnings per share for the last twelve months|BCLI: Net earnings per share (EPS TTM)|Cara Therapeutics Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corporation|Earnings per share for the last 12 months ELYM (Eliem)|Net earnings per share (EPS TTM) ITCI|LBPH - Net earnings per one share for the last twelve months|Marinus Pharmaceuticals, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) NKGen Biotech Inc NKGN|NRBO - Earnings per share for the last twelve months|Earnings per share for the trailing year SAGE (Sage Therapeutics Inc)|Synaptogenix, Inc. (SNPX) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months trevena.com (TRVN)|Earnings per share for the last twelve months Vigil Neuroscience Inc.|Net earnings per share for the last 12 months Anew Medical Inc. (WENA)|Net earnings per share (EPS TTM) CERE
